Search results
Cancer vaccines are having a renaissance
Technology Review· 1 day agoPersonalized cancer vaccines like the ones Moderna and BioNTech are developing are tailored to each patient’s particular cancer. Together these neoantigens form a kind of ...
Insider Sale at Vaxcyte Inc: COO Jim Wassil Sells 3,000 Shares
GuruFocus.com via Yahoo Finance· 1 hour agoThe transaction was filed with the SEC and can be viewed in detail through the SEC Filing. Vaxcyte...
New mRNA cancer vaccine triggers immune system to fight aggressive brain tumour
PA Media: Science via Yahoo News· 3 days agoA new personalised brain cancer jab can trigger the body’s own immune system to attack the most...
Supreme Court rejected military chaplains' lawsuit saying their careers were ruined after refusing...
Business Insider· 2 days agoThe Supreme Court denied military chaplains' lawsuit claiming retaliation for refusing the COVID-19 ...
No More Yearly Flu Shots? Vaccine Mixed From 80,000 Proteins Could Be The Key
IFLScience· 2 days agoA new vaccine strategy could spell the end of yearly flu shots, by targeting part of the virus that...
In the event of a bird flu pandemic, vaccines could be available within 4 months, according to the...
Hardwood Paroxysm· 8 hours agoIts genetic makeup will certainly be different from that currently found in nature, especially in...
MRNA Vaccine Fights Deadly Brain Tumor in Small Trial
WFMZ Eastern Pennsylvania and Western New Jersey· 2 days agoAn experimental cancer vaccine can quickly reprogram a person’s immune system to attack...
Backlogged: Few cases finished after millions spent investigating COVID vaccine claims
Valley News Live· 5 days agoOn the extremely rare occasions that a vaccine meant to protect public health harms a patient, the...
Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch
Market Watch· 2 days agoModerna Inc. on Thursday reported a narrower-than-expected first-quarter loss as the COVID vaccine...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 2 days agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...